Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and ...
The USA has completed its withdrawal from the World Health Organization (WHO), according to a joint announcement by the US ...
Australian biotech Neurizon Therapeutics (ASX: NUZ) is setting out to redefine how neurodegenerative diseases are treated, ...
In a new report, DelveInsight argues the gastroesophageal reflux disease market remains constrained by limited approved ...
Belgian biopharma UCB has announced a capital boost from the UK government’s Life Sciences Innovative Manufacturing Fund ...
Canadian pharma company Bausch Health has announced the results of the global Phase III RED-C clinical program.
Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today, the UK health technology assessor, National Institute ...
The Russian government has extended the permit for domestic pharmaceutical companies Promomed and PSK Pharma to produce ...
US biopharma Corcept Therapeutics (Nasdaq: CORT) says its Phase III ROSELLA trial met its overall survival primary endpoint ...
South Korea’s Samsung Bioepis today released its first quarter 2026 biosimilar market report, marking the twelfth edition of ...
Japanese pharma Daiichi Sankyo (TSE: 4568) and British partner AstraZeneca (LSE: AZN) said Enhertu (trastuzumab deruxtecan) ...
Japanese drugmaker Daiichi Sankyo has appointed Veronika Rozehnal to succeed Jürgen Müller as the Head of the Translational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results